River Stone Biotech ISG ApS: Financial statements 2023
CVR: 42596787
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
River Stone Biotech ISG ApS (CVR 42596787) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,625,265 and a net result of DKK -1,109,600 compared with DKK -2,398,558 the year before. That is a decrease of 68.5% compared with the year before. Equity in the 2023 report amounted to DKK -245,584.
- Gross Profit
- DKK 1,625,265
- Profit/Loss
- DKK -1,109,600
- Equity
- DKK -245,584
- Total Assets
- DKK 3,482,848
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
River Stone Biotech ISG ApS has published its annual report for 2022. Gross profit came to DKK 5,153,513, and the net result was DKK -2,398,558.
About River Stone Biotech ISG ApS
River Stone Biotech ISG ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company has been dissolved on 20 June 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 1,625,265 and a net result of DKK -1,109,600 compared with DKK -2,398,558 the year before. Equity in the 2023 report amounted to DKK -245,584.